Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L01 ANTINEOPLASTIC AGENTS
      L01X OTHER ANTINEOPLASTIC AGENTS
        L01XX Other antineoplastic agents
          L01XX44 Aflibercept
            D09574  Aflibercept (USAN/INN) <JP/US>
  S SENSORY ORGANS
    S01 OPHTHALMOLOGICALS
      S01L OCULAR VASCULAR DISORDER AGENTS
        S01LA Antineovascularisation agents
          S01LA05 Aflibercept
            D09574  Aflibercept (USAN/INN) <JP/US>

USP drug classification [BR:br08302]
  Ophthalmic Agents
    Ophthalmic Agents, Other
      Vascular Endothelial Growth Factor (VEGF) Inhibitor
        Aflibercept
          D09574  Aflibercept (USAN/INN)

Therapeutic category of drugs in Japan [BR:br08301]
  1  Agents affecting nervous system and sensory organs
    13  Agents affecting sensory organs
      131  Ophthalmic agents
        1319  Others
          D09574  Aflibercept (USAN/INN); Aflibercept (genetical recombination) (JAN)	L01XX44 S01LA05

Target-based classification of drugs [BR:br08310]
  Cytokines and receptors
    Cytokines
      Growth factors (RTK-binding)
        PGF [HSA:5228] [KO:K16859]
          D09574  Aflibercept (USAN/INN) <JP/US>
        VEGFA [HSA:7422] [KO:K05448]
          D09574  Aflibercept (USAN/INN) <JP/US>
        VEGFB [HSA:7423] [KO:K16858]
          D09574  Aflibercept (USAN/INN) <JP/US>

[ BRITE | KEGG2 | KEGG ]